By proceeding, you agree to our Terms of Use and Privacy Policy.
Supercharge Your LNP Product Quality to Expedite Novel Treatments to Patients | Embrace Technology Innovations to Optimize LNP Formulation, Stability & Process Control to Achieve Seamless Scale-Up, Compliance & Cost Effectiveness With the global nanopharmaceutical drug market poised to reach $82.
The speakers will share insights on SARS-COV-2 vaccine and delve into the physiochemistry of LNP to scale-up in a cost effective and compliant manner.
Explore the possibilities of lipid nanoparticles and discuss the formulation of LNP therapeutics to accelerate the application of true remedies.
Network with experts to overcome the challenges in the process and formulation of LNP therapeutics to advance alternative therapy and partnerships.
Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialised fields to provide unmatched depth and quality of content. We work in sectors where quality of information is the difference between success and failure.
Founded in 2019, Arranta Bio is a visionary contract development and manufacturing organization (CDMO) that partners with companies seeking to develop and manufacture complex biological drugs and innovative therapies.
Advanced Instruments is the global leader of freezing-point osmometry and analytical instrumentation used in clinical, pharmaceutical, biotechnology and food & beverage laboratories.
aexeRNA Therapeutics is developing mRNA therapeutics utilizing its proprietary next generation programmable and highly potent Lipid Nanoparticle (LNP) nucleic acid delivery system.
Scientists are driven by powerful ideas to develop innovative molecules that can save lives. But to bring their drug to market, they must navigate pharmaceutical manufacturing, clinical trials, logistical complexities and strict regulations.
Micropore Technologies supports its clients’ journeys towards the greening of their formulated products and their contribution to a circular economy.
PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases.
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.